Dynamic thiol/disulphide homeostasis before and after radical prostatectomy in patients with prostate cancer
暂无分享,去创建一个
O. Erel | A. Cuoghi | T. Ozben | A. Tomasi | A. Hanikoğlu | Ferhat Hanikoglu | M. Baykara | M. Alışık | E. Kucuksayan | Ahmet Anil Gocener | Ferhat Hani̇koğlu
[1] Michael Gronow,et al. Determination of cellular glutathione:glutathione disulfide ratio in prostate cancer cells by high performance liquid chromatography with electrochemical detection. , 2016, Journal of chromatography. A.
[2] O. Erel,et al. Oxidative Stress and Periodontal Disease in Obesity , 2016, Medicine.
[3] O. Erel,et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. , 2016, Journal of the American Society of Hypertension : JASH.
[4] M. Comini. Measurement and meaning of cellular thiol:disufhide redox status , 2016, Free radical research.
[5] F. Zorlu,et al. Predictive factors for biochemical recurrence in radical prostatectomy patients , 2015, Central European journal of urology.
[6] O. Erel,et al. How does thiol/disulfide homeostasis change in prediabetic patients? , 2015, Diabetes research and clinical practice.
[7] Xinghuan Wang,et al. Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer. , 2015, American journal of cancer research.
[8] M. Rubens,et al. Selenium and vitamin E for prostate cancer--justifications for the SELECT study. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[9] S. Gangemi,et al. Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review , 2014, Urologia Internationalis.
[10] O. Erel,et al. A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.
[11] C. Kuo,et al. Intracellular Glutathione Depletion by Oridonin Leads to Apoptosis in Hepatic Stellate Cells , 2014, Molecules.
[12] W. Zhong,et al. Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression. , 2014, Free radical biology & medicine.
[13] Klaus-Peter Adam,et al. Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth , 2013, Cancer research.
[14] Rafael Radi,et al. The thiol pool in human plasma: the central contribution of albumin to redox processes. , 2013, Free radical biology & medicine.
[15] M. Smeyne,et al. Glutathione metabolism and Parkinson's disease. , 2013, Free radical biology & medicine.
[16] J. Mieyal,et al. Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. , 2012, Antioxidants & redox signaling.
[17] R. Pecoits-Filho,et al. Plasma Cysteine/Cystine Reduction Potential Correlates with Plasma Creatinine Levels in Chronic Kidney Disease , 2012, Blood Purification.
[18] Jian-Min Yuan,et al. Green and black tea intake in relation to prostate cancer risk among Singapore Chinese , 2012, Cancer Causes & Control.
[19] Dean P. Jones,et al. Cysteine/cystine redox signaling in cardiovascular disease. , 2011, Free radical biology & medicine.
[20] Yücel Şahin,et al. Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. , 2010, Indian journal of biochemistry & biophysics.
[21] E. Matteucci,et al. Thiol Signalling Network with an Eye to Diabetes , 2010, Molecules.
[22] N. Matevska,et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. , 2009, Clinical biochemistry.
[23] M. Srougi,et al. Pretreatment Tumor Volume Estimation Based on Total Serum PSA in Patients with Localized Prostate Cancer , 2008, Clinics.
[24] R. D. Mittal,et al. Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer , 2005, Indian Journal of Clinical Biochemistry.
[25] N. Baral,et al. Oxidative stress in benign prostate hyperplasia. , 2007, Nepal Medical College journal : NMCJ.
[26] E. Vazquez,et al. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer , 2007, British Journal of Cancer.
[27] A. Aydın,et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. , 2006, Clinical biochemistry.
[28] O. Erel,et al. A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.
[29] Dean P. Jones,et al. Glutathione redox potential in response to differentiation and enzyme inducers. , 1999, Free radical biology & medicine.
[30] G. Aykaç-toker,et al. Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive , 1999, Journal of Cancer Research and Clinical Oncology.
[31] L. Oberley,et al. Expression of antioxidant enzymes in human prostatic adenocarcinoma , 1997, The Prostate.
[32] G. Wilding,et al. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. , 1997, Journal of the National Cancer Institute.